Quick Answer
HOOKIPA Pharma Inc. reported Net Income of -$43.50 million for fiscal year 2024.
HOOKIPA Pharma Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$43.50M | +46.7% |
| 2023 | -$81.58M | -25.7% |
| 2022 | -$64.92M | +14.2% |
| 2021 | -$75.67M | -71.6% |
| 2020 | -$44.08M | -2.4% |
| 2019 | -$43.04M | -165.1% |
| 2018 | -$16.24M | -27.6% |
| 2017 | -$12.72M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$15.43M | -207.3% | -11.5% |
| September 30, 2024 | -$13.84M | +27.4% | +27.5% |
| June 30, 2024 | -$19.09M | -6.0% | -232.8% |
| March 31, 2024 | $14.38M | +173.1% | +175.4% |
| September 30, 2023 | -$19.07M | -4.3% | -5.8% |
| June 30, 2023 | -$18.02M | -10.1% | +8.5% |
| March 31, 2023 | -$19.68M | -9.5% | -7.7% |
| September 30, 2022 | -$18.28M | +8.8% | -11.8% |
- HOOKIPA Pharma Inc. showed an increase of +46.7% in Net Income compared to the prior fiscal year.
- Over the 2017–2024 period, HOOKIPA Pharma Inc.’s net income has declined by 241.9% (from -$12.72 million to -$43.50 million).
- The most recent figure is from HOOKIPA Pharma Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 28, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: